Since the EU ban in 2006 of antimicrobials for prophylactic
and sub-therapeutic purposes in aquaculture to counter the spread of antibiotic
resistance alternative methods have been sought to increase yields and combat
disease. Probiotics that positively influence the microbial community within a
rearing environment, or within a target species itself leading to increased
disease resistance or/and upregulated immune responses, and improved growth
rate/feed conversion are becoming increasingly popular functional components of
modern aquaculture.
Aranda et al. (2012),
investigated the antimicrobial activity of Pseudoalteromonas
spp. - isolated from Chilean mussels (Perumytilus
purpuratus) - against the opportunistic fish, shellfish, and human pathogen
Vibrio parahaemolyticus. Pseudoalteromonas spp. have previously
been identified as producing biologically active antibacterial, antifouling,
and antibiofilm compounds and the authors wished to identify a possible use as
a probiotic in Chilean aquaculture.
18 culturable Pseudoalteromonas spp. bacterial
isolates from the mussel were found to inhibit growth in V. parahaemolyticus. 16S rRNA gene sequence identification and
phylogenetic analysis of the three most prolific isolates (DIT09, DIT44, DIT46)
indicated a well-supported clade of Pseudoalteromonas
with close identity to P. prydzensis (99 % identity) and P. mariniglutinosa (98 % identity). Antimicrobial
activity for these strains was also positive against V. cholerae and V.
anguillarum but not against other bacterial genera indicating a specificity
for vibrios.
The antimicrobial compounds released by the DIT strains were
extracellular and permeable through membranes with a 3 kDa cut-off, were
ethanol soluble, and produced in late exponential growth phase (24 hrs).
Interestingly after late exponential phase antimicrobial activity decreased
until it was undetectable (96 hrs). High performance liquid chromatography (HPLC) analysis
revealed that the active antibiotic compound was likely amphiphilic and identified
3 bioactive molecules for strain DIT09, 6 bioactive molecules for DIT44, and 5
bioactive molecules for strain DIT46.
The mode of action of the bioactive compounds was suggested
as bacteriostatic, but not bactericidal as growth was inhibited but the
bacterium not killed. A suggested mode of action of this bacteriostatic was
that it interfered with the iron acquisition and siderophore machinery of V. parahaemolyticus in a competitive
manner, as addition of iron into the culture medium reversed the bacteriostatic
action.
Finally, all three DIT strains were subject to ecotoxicology
tests to indicate their usefulness as a potential probiotic. Acute (cell free
extracts) and chronic (3.3 x 103 cfu/ml) ecotoxicological tests
utilising Artemia franciscana nauplii
did not cause any significant mortality. However, the inferences of this
ecotoxicological test must be very limited as organism responses are likely to
be highly species specific, and a lack of mortality does not necessarily mean a
lack of harm.
This study is a useful contribution in the search for novel
probiotic bacteria. The characterisation of novel anti-vibrio compounds is an
exciting development as vibrios cause numerous diseases and severe mortality in
aquaculture. The potential application for human medicine in treating vibrio
diseases should also be considered. However, before the probiotic application
of this bacterium should be considered further research into its interactions
with other beneficial bacteria and host organism should be considered. The
authors did note that although the DIT strains were sensitive to most
antibiotics it was intermediately resistant to erythromycin. The potential for the dissemination of erythromycin
resistance to potentially pathogenic bacteria may preclude the strains in this
study from being applicable for probiotic use.
Reference:
Aranda, C. P., Valenzuela, C., Barrientos, J., Paredes, J., Leal, P., Maldonado, M., ... & Osorio, C. G. (2012). Bacteriostatic anti-Vibrio parahaemolyticus activity of Pseudoalteromonas sp. strains DIT09, DIT44 and DIT46 isolated from Southern Chilean intertidal Perumytilus purpuratus. World Journal of Microbiology and Biotechnology, 28(6), 2365-2374.
Reference:
Aranda, C. P., Valenzuela, C., Barrientos, J., Paredes, J., Leal, P., Maldonado, M., ... & Osorio, C. G. (2012). Bacteriostatic anti-Vibrio parahaemolyticus activity of Pseudoalteromonas sp. strains DIT09, DIT44 and DIT46 isolated from Southern Chilean intertidal Perumytilus purpuratus. World Journal of Microbiology and Biotechnology, 28(6), 2365-2374.
This comment has been removed by the author.
ReplyDeleteMorning Matt,
ReplyDeleteMany thanks for an interesting post. I must say, I am finding these posts on fish aquaculture and probiotics/other treatments hugely engaging. Though in Dans last lecture he mentioned towards the end that only one single probiotic has ever been approved in Europe, and even this took years and millions of pounds to become accepted. Bearing this in mind, as far as European aquaculture is concerned, do you feel probiotics such as the afore mentioned are of feasible use and worth putting such huge amounts of money into? Obviously other countries are slightly less picky, but to discover probiotics that can actually be used in European aquaculture, the efforts and money must be enormous! What do you think?
Many thanks, Sam
This comment has been removed by the author.
ReplyDeleteThis comment has been removed by the author.
ReplyDeleteGood afternoon Sam. As for as I am aware Bactocell produced by Lallemand is the only EU approved LAB probiotic for aquaculture I could find. However I'm not sure this precludes the use of other probiotics as there are so many on the market, maybe somebody can clarify?
ReplyDeletehttp://ec.europa.eu/food/food/animalnutrition/feedadditives/comm_register_feed_additives_1831-03.pdf